Bio-Rad Laboratories Inc (BIO)

454.43 +2.94  +0.65% NYSE Jul 1, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
07/31/2020 17:00 EDT Misc Bio-Rad Laboratories Inc Second Quarter Earnings Conference Call in 2020
07/31/2020 Earnings Bio-Rad Laboratories Inc Second Quarter Earnings in 2020 Release
05/06/2020 17:00 EDT Misc Bio-Rad Laboratories Inc First Quarter Earnings Conference Call for 2020
05/06/2020 Earnings Bio-Rad Laboratories Inc First Quarter Earnings Result for 2020
04/28/2020 16:00 PDT Misc Bio-Rad Laboratories Inc Annual General Meeting for 2019
03/02/2020 Misc Bio-Rad Laboratories Inc Annual Report for 2019
02/13/2020 17:00 EST Misc Bio-Rad Laboratories Inc Fourth Quarter Earnings Conference Call for 2019
02/13/2020 Earnings Bio-Rad Laboratories Inc Fourth Quarter Earnings in 2019 Release
10/31/2019 17:00 EDT Misc Bio-Rad Laboratories Inc Third Quarter Earnings Conference Call for 2019
10/31/2019 Earnings Bio-Rad Laboratories Inc Third Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.bio-rad.com
  • Investor Relations URL: http://www.bio-rad.com/en-us/corporate/investor-relations
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Medical Devices
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Jul. 31, 2020
  • Last Earnings Release: May. 06, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Bio-Rad Laboratories Inc manufactures and supplies systems used to separate and analyze chemical and biological materials to life sciences and healthcare companies. The firm has two business segments: life science and clinical diagnostics. The life sciences segment manufactures reagents and laboratory instruments used by researchers, food producers, and pharmaceutical manufacturers. The clinical diagnostics segment generates over half of the firm's revenue and creates tests systems, informatics systems, test kits, and specialized quality controls for diagnostic labs. It also sells in vitro diagnostic tests to clinical laboratories. Most of the firm's revenue is generated from the United States and Europe.

Top Fund Holders

Symbol Name Weighting
BAWAX Brown Advisory Sustainable Growth Adv 3.24%
ATERX AB Sustainable Global Thematic R 2.93%
WOFRX Wells Fargo Opportunity R6 2.73%
FXH First Trust Health Care AlphaDEX® ETF 2.44%
SMCPX ClearBridge Mid Cap 1 2.33%
WDSCX Wells Fargo Discovery C 1.64%
RVT Royce Value Trust 0.93%
IHI iShares US Medical Devices ETF 0.91%
MDY SPDR® S&P MIDCAP 400 ETF Trust 0.69%
IVOO Vanguard S&P Mid-Cap 400 ETF 0.68%
VISGX Vanguard Small Cap Growth Index Inv 0.62%
VBK Vanguard Small-Cap Growth ETF 0.62%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.